General form of registration statement for all companies including face-amount certificate companies

Commitments and Contingencies (Details Narrative)

v3.20.2
Commitments and Contingencies (Details Narrative)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended 36 Months Ended
Sep. 26, 2019
USD ($)
Sep. 13, 2018
USD ($)
Sep. 13, 2018
EUR (€)
Aug. 12, 2016
USD ($)
May 05, 2016
USD ($)
May 04, 2016
USD ($)
May 30, 2017
USD ($)
Jun. 30, 2012
Jun. 30, 2018
USD ($)
Mar. 31, 2020
USD ($)
shares
Jun. 30, 2019
USD ($)
Jun. 30, 2018
USD ($)
Mar. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Jul. 02, 2019
USD ($)
Convertible note                   $ 169,500          
Penalty amount                         $ 30,000 $ 30,000  
Operating lease term                     5 years        
Right-of-use assets                 24,959      
Total lease liabilities                   27,335          
Contract cost                     49,854        
Royalties percentage   2.00% 2.00%                        
Accounting Standards Update 2016-02 [Member]                              
Right-of-use assets                             $ 46,696
Total lease liabilities                             $ 46,696
Incremental borrowing rate                             6.00%
Royalty Agreement Terms [Member]                              
Operating leases income statement revenue percentage               2.00%              
License Agreement Terms [Member]                              
Operating leases income statement revenue percentage               5.00%              
New Five-Year Operating Lease Agreement [Member]                              
Operating lease term         5 years                    
Payments for rent         $ 2,469 $ 2,325                  
New Five-Year Operating Lease Agreement [Member] | AUD Currency [Member]                              
Payments for rent         $ 3,606                    
Manufacturing Services Agreement [Member] | Minimum [Member]                              
Anticipated milestone payment       $ 2,500,000                      
Manufacturing Services Agreement [Member] | Maximum [Member]                              
Anticipated milestone payment       $ 5,000,000                      
Amatsigroup Agreement [Member]                              
Payments description       The Company anticipates that its payments to Amatsigroup under the MSA will range between $2.5 million and $5.0 million over three years, when the finished drug product is manufactured and released for clinical trials. The Company has spent a total of $1,689,146 of costs to date under this contract of which $1,689,146 was expensed in prior years. The MSA shall continue for a term of three years unless extended by mutual agreement in writing with a possible extension currently under consideration.                      
Contract cost                   1,689,146 $ 1,689,146 $ 1,689,146      
One-Year Collaboration Agreement [Member]                              
Payment for services   $ 59,508                          
One-Year Collaboration Agreement [Member] | Euros [Member]                              
Payment for services | €     € 52,000                        
Two-Year Collaboration Agreement [Member]                              
Payment for services   $ 45,775                          
Two-Year Collaboration Agreement [Member] | Euros [Member]                              
Payment for services | €     € 40,000                        
From 2012 through the 2014 [Member]                              
Penalty amount                 $ 10,000 10,000          
Regal Consulting, LLC [Member]                              
Loss contingency amount                   $ 400,000          
Number of shares issued for services | shares                   60,000          
Regal Consulting, LLC [Member] | 2017 Note [Member]                              
Convertible note             $ 106,500                
Penalty amount             $ 98,000                
Foley Shechter [Member]                              
Legal fees $ 151,032                            
Potential liability reduction $ 51,032